Home monitoring of implantable cardioverter defibrillators reduced estimated 5-year follow-up costs by $2,149, with net savings beginning after a mean of 33.5 months compared to conventional care.
Observational (n=502)
Sí
Home monitoring (HM) of cardioverter defibrillators (ICD) with its automated wireless remote data access, may decrease the rate of patient visits. This study examined the potential cost savings for the long-term care of ICD assisted by HM. A French database including 502 patients from 6 university hospitals was used. Costs of conventional follow-up (FU) of ICD were calculated without, and compared with the expected cost of FU with HM. Calculations included number of visits, including physician's fees, electrocardiograms, and specific ICD surveillance, and transportation costs. The mean distance between home and institutions performing follow-ups was 69 +/- 57 km. For each visit, a mean overall cost of 215 dollars was calculated, including 121 dollars for transportation and 94 dollars for medical services. HM may obviate up to 2 visits per year. Over the 5 years of expected life of the device, the decrease in costs for FU visits was estimated at 2,149 dollars. With an additional cost of 1,200 dollars for the HM system, saving began after a mean FU of 33.5 months. The time to onset of cost saving by HM ranged between 17.4 months for patients living >150 km from the medical facility to 52.2 months for those living 100 km.
Fauchier et al. (Sat,) conducted a observational in Implantable Cardioverter Defibrillator (ICD) recipients (n=502). Home monitoring (HM) of cardioverter defibrillators vs. Conventional follow-up was evaluated on Cost savings for long-term care. Home monitoring of implantable cardioverter defibrillators reduced estimated 5-year follow-up costs by $2,149, with net savings beginning after a mean of 33.5 months compared to conventional care.